The findings indicate that AYN has the potential to activate the AMPKα/GLUT4 signaling pathway in both in vivo and in vitro settings, thereby ameliorating hyperglycemia associated with diabetes. This evidence concerns the gene SLC2A4 and diabetes mellitus.